TapewireFind a company

person · Reporting owner

Kurzius Lawrence Erik

Disclosed activity across 4 companies

Tapewire entity
20811
SEC CIK
0001352090

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
COOPER COMPANIES, INC.COO · Entity 3395DirectorSeptember 16, 2026September 17, 2026
Elanco Animal Health IncELAN · Entity 3457DirectorAugust 20, 2026August 21, 2026
Lamb Weston Holdings, Inc.LW · Entity 3684DirectorOctober 08, 2026October 09, 2026
MCCORMICK & CO INCMKC · Entity 141610% ownerAugust 10, 2026August 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

COOPER COMPANIES, INC.

Report date September 16, 2026 · Filed September 17, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect31,099 Reported balance After 2026-09-16 transaction · row 1
1 source row

Row 1 · 2026-09-16 · Purchase · Acquired 10,000 · Balance 31,099

Elanco Animal Health Inc

Report date August 20, 2026 · Filed August 21, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect188,647 Reported balance After 2026-08-20 transaction · row 1
1 source row

Row 1 · 2026-08-20 · Purchase · Acquired 40,000 · Balance 188,647

F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Lamb Weston Holdings, Inc.

Report date October 08, 2026 · Filed October 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect11,054 Reported balance After 2026-10-08 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-10-08 · Grant · Acquired 5,458 · Balance 11,054

F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.

F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.

MCCORMICK & CO INC

Report date August 10, 2026 · Filed August 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock - VotingSEC Table I · non-derivativeDirect296,992 Ending reported balance After 2026-08-10 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-08-10 · Exercise / conversion · Acquired 205,538 · Balance 502,530

Row 2 · 2026-08-10 · Sale · Disposed 205,538 · Balance 296,992

Options - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2027-03-29Direct0 Reported balance After 2026-08-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-08-10 · Exercise / conversion · Disposed 205,538 · Balance 0

F1: Option exercised; no purchase price required.

Filing footnotes · ownership attribution and instrument terms

F1: Option exercised; no purchase price required.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 30, 2022 Filed Jan 3, 2023 22:09 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 750.1367 $12.22 $9,166.67
Disclosure

SEC source: 0001415889-23-000091 · form4-01032023_100126.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,214.568

Underlying: Common Stock · 750.1367 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:04 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 712.251 $12.87 $9,166.67
Disclosure

SEC source: 0001415889-22-011972 · form4-12022022_101203.xml · derivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,464.4313

Underlying: Common Stock · 712.251 shares

Expires not disclosed

F2 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F3 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:04 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011972 · form4-12022022_101203.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,916

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:27 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 694.9712 $13.19 $9,166.67
Disclosure

SEC source: 0001415889-22-010995 · form4-11022022_011133.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,752.1803

Underlying: Common Stock · 694.9712 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
October 25, 2022 Filed Jan 25, 2023 18:19 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherPhantom Stock · Derivative 145.65 $76.13 $11,088.33
Disclosure

SEC source: 0001062993-23-001361 · form4.xml · derivative · entry 9

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Non Qualified Retirement Savings Plan

Disclosed balance after: 30,113.934

Underlying: Common Stock - Voting · 145.65 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend Reinvestment.

F1 · derivative.exercise_date: Dividend Reinvestment.

F1 · derivative.expiration_date: Dividend Reinvestment.

Read SEC document
October 24, 2022 Filed Oct 25, 2022 21:34 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Non Voting 2,500 $74.53 $186,324.25
Disclosure

SEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 10

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
October 24, 2022 Filed Oct 25, 2022 21:34 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Non Voting 2,500 $74.30 $185,750.00
Disclosure

SEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 9

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Read SEC document
October 21, 2022 Filed Oct 25, 2022 21:34 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherCommon Stock - Non Voting 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 8

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · price: Exchange of shares of Common Stock - Voting for shares of Common Stock - Non-Voting on a one for one basis.

Read SEC document
October 21, 2022 Filed Oct 25, 2022 21:34 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherCommon Stock - Voting 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-021103 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,898

F1 · price: Exchange of shares of Common Stock - Voting for shares of Common Stock - Non-Voting on a one for one basis.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:51 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 738.6519 $12.41 $9,166.67
Disclosure

SEC source: 0001415889-22-010280 · form4-10042022_021057.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,057.2091

Underlying: Common Stock · 738.6519 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
August 31, 2022 Filed Sep 2, 2022 20:06 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 605.8605 $15.13 $9,166.67
Disclosure

SEC source: 0001415889-22-009257 · form4-09022022_010919.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,318.5572

Underlying: Common Stock · 605.8605 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 20:36 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 452.4516 $20.26 $9,166.67
Disclosure

SEC source: 0001415889-22-008117 · form4-08022022_010838.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,712.6967

Underlying: Common Stock · 452.4516 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
July 25, 2022 Filed Jan 25, 2023 18:19 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherPhantom Stock · Derivative 130.545 $84.57 $11,040.19
Disclosure

SEC source: 0001062993-23-001361 · form4.xml · derivative · entry 8

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Non-Qualified Retirement Plan

Disclosed balance after: 29,968.284

Underlying: Common Stock - Voting · 130.545 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend Reinvestment.

F1 · derivative.exercise_date: Dividend Reinvestment.

F1 · derivative.expiration_date: Dividend Reinvestment.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 22:33 UTC MCCORMICK & CO INC MKC · Entity 1416 GrantOptions- Right to Buy · Derivative 17,806 $0.00 Strike: $83.25 $0.00
Disclosure

SEC source: 0001062993-22-015972 · form4.xml · derivative · entry 11

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,806

Underlying: Common Stock - Voting · 17,806 shares

Expires not disclosed

F6 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.

F6 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 20:32 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 466.9725 $19.63 $9,166.67
Disclosure

SEC source: 0001415889-22-007334 · form4-07052022_010737.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,260.2451

Underlying: Common Stock · 466.9725 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 23:52 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 386.7793 $23.70 $9,166.67
Disclosure

SEC source: 0001415889-22-006044 · form4-06022022_040621.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,793.2726

Underlying: Common Stock · 386.7793 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
April 29, 2022 Filed May 3, 2022 21:31 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 362.1758 $25.31 $9,166.67
Disclosure

SEC source: 0001415889-22-004544 · form4-05032022_020537.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,406.4933

Underlying: Common Stock · 362.1758 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
April 27, 2022 Filed Jul 5, 2022 22:33 UTC MCCORMICK & CO INC MKC · Entity 1416 GiftCommon Stock - Voting 2,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-015972 · form4.xml · nonDerivative · entry 5

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2020 GRAT B

Disclosed balance after: 7,655

F2 · price: Shares gifted; No Purchase price required.

F1 · balance_after: Upon termination of the Reporting Person's 2020 grantor retained annuity trusts, the Reporting Person gifted 4,418 shares of Common Stock - Voting and transferred 10,892 shares of Common Stock - Voting evenly into two new separate grantor retained annuity trusts created on June 30, 2022.

Read SEC document
April 27, 2022 Filed Jul 5, 2022 22:33 UTC MCCORMICK & CO INC MKC · Entity 1416 GiftCommon Stock - Voting 2,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-015972 · form4.xml · nonDerivative · entry 4

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2020 GRAT A

Disclosed balance after: 7,655

F2 · price: Shares gifted; No Purchase price required.

F1 · balance_after: Upon termination of the Reporting Person's 2020 grantor retained annuity trusts, the Reporting Person gifted 4,418 shares of Common Stock - Voting and transferred 10,892 shares of Common Stock - Voting evenly into two new separate grantor retained annuity trusts created on June 30, 2022.

Read SEC document
April 27, 2022 Filed Jul 6, 2022 20:03 UTC Amendment MCCORMICK & CO INC MKC · Entity 1416 GiftCommon Stock - Voting 2,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-016060 · form4a.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2020 GRAT B

Disclosed balance after: 0

F1 · price: Shares gifted; No Purchase price required.

F2 · balance_after: The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned by the reporting person indirectly through the reporting person's 2020 GRATs following the reported transactions.

Read SEC document
April 27, 2022 Filed Jul 6, 2022 20:03 UTC Amendment MCCORMICK & CO INC MKC · Entity 1416 GiftCommon Stock - Voting 2,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-016060 · form4a.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2020 GRAT A

Disclosed balance after: 0

F1 · price: Shares gifted; No Purchase price required.

F2 · balance_after: The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned by the reporting person indirectly through the reporting person's 2020 GRATs following the reported transactions.

Read SEC document
April 25, 2022 Filed Jul 5, 2022 22:33 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherPhantom Stock · Derivative 107.457 $102.37 $11,000.37
Disclosure

SEC source: 0001062993-22-015972 · form4.xml · derivative · entry 10

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Non-Qualified Retirement Plan

Disclosed balance after: 29,837.739

Underlying: Common Stock - Voting · 107.457 shares

Expires not disclosed

F4 · derivative.exercise_price: Dividend Reinvestment.

F4 · derivative.exercise_date: Dividend Reinvestment.

F4 · derivative.expiration_date: Dividend Reinvestment.

F5 · balance_after: This amount reflects 299.064 shares acquired through Dividend Reinvestment and not previously reported on the Reporting Person's previous Form 4.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 21:54 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 351.348 $26.09 $9,166.67
Disclosure

SEC source: 0001415889-22-003755 · form4-04042022_020422.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,044.3175

Underlying: Common Stock · 351.348 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 30, 2022 Filed Apr 1, 2022 15:39 UTC MCCORMICK & CO INC MKC · Entity 1416 GrantOptions- Right to Buy · Derivative 194,219 $0.00 Strike: $97.26 $0.00
Disclosure

SEC source: 0001062993-22-009177 · form4.xml · derivative · entry 9

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,219

Underlying: Common Stock - Voting · 194,219 shares

Expires not disclosed

F2 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.

F2 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.

Read SEC document
March 30, 2022 Filed Jun 2, 2022 20:23 UTC Amendment MCCORMICK & CO INC MKC · Entity 1416 GrantOptions- Right to Buy · Derivative 178,368 $0.00 Strike: $97.26 $0.00
Disclosure

SEC source: 0001062993-22-014143 · form4a.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,368

Underlying: Common Stock - Voting · 178,368 shares

Expires not disclosed

F1 · derivative.exercise_date: The option grant becomes exercisable in thirds of the first three (3) grant anniversaries.

F1 · derivative.expiration_date: The option grant becomes exercisable in thirds of the first three (3) grant anniversaries.

F2 · balance_after: Due to an administrative error, the Reporting Person's previous Form 4 filed on April 1, 2022 incorrectly reported the Reporting Person receiving an option grant of 194,219 shares of Common Stock - Voting when it should have been reported as 178,368 shares of Common Stock - Voting.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 19:34 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionRestricted Stock Units · Derivative 7,966 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-008017 · form4.xml · derivative · entry 13

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,970

Underlying: Common Stock - Voting · 7,966 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required.

F6 · price: Restricted Stock Units granted on April 1, 2020.

F5 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023.

F5 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 19:34 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionRestricted Stock Units · Derivative 6,994 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-008017 · form4.xml · derivative · entry 12

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 6,994 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required.

F4 · price: Restricted Stock Units granted on March 27, 2019

F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2020, March 15, 2021 and March 15, 2022

F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2020, March 15, 2021 and March 15, 2022

Read SEC document
March 15, 2022 Filed Mar 17, 2022 19:34 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 3,661 $96.99 $355,080.39
Disclosure

SEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 4

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,898

Read SEC document
March 15, 2022 Filed Mar 17, 2022 19:34 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 7,966 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units; No purchase price required.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 19:34 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 3,214 $96.99 $311,725.86
Disclosure

SEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,593

Read SEC document
March 15, 2022 Filed Mar 17, 2022 19:34 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 6,994 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-008017 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units; No purchase price required.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 22:49 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 322.6565 $28.41 $9,166.67
Disclosure

SEC source: 0001179110-22-001941 · edgar.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,692.9695

Underlying: Common Stock · 322.6565 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
February 13, 2022 Filed Feb 15, 2022 19:18 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 39,224 $101.02 $3,962,212.36
Disclosure

SEC source: 0001062993-22-004413 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,813

F1 · shares: Shares withheld for taxes on the shares previously reported on 1/26/2022 for McCormick's Long-Term Incentive Plan.

Read SEC document
January 31, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions - Right to Buy · Derivative 90,000 $0.00 Strike: $35.55 $0.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · derivative · entry 17

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 90,000 shares

Expires 2024-03-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Options Exercised.

Read SEC document
January 31, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 90,000 $100.09 $9,007,659.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 6

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,037

Read SEC document
January 31, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 90,000 $35.55 $3,199,500.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 5

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,037

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 31, 2022 Filed Feb 3, 2022 01:36 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 352.0226 $26.04 $9,166.67
Disclosure

SEC source: 0001179110-22-000724 · edgar.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,370.313

Underlying: Common Stock · 352.0226 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionOptions- Right to Buuy · Derivative 8,400 $0.00 Strike: $35.55 $0.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · derivative · entry 16

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 8,400 shares

Expires 2024-03-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Options Exercised.

Read SEC document
January 28, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 SaleCommon Stock - Voting 8,400 $98.00 $823,200.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 4

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,037

Read SEC document
January 28, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 8,400 $35.55 $298,620.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 3

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 24, 2022 Filed Jan 26, 2022 20:34 UTC MCCORMICK & CO INC MKC · Entity 1416 GrantCommon Stock - Voting 81,208 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-001605 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,037

F1 · shares: Shares awarded pursuant to McCormick's Long-Term Incentive Program (LTIP) for the three (3) year performance cycle beginning on December 1, 2018 and ending on November 30, 2021.

Read SEC document
January 10, 2022 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 OtherPhantom Stock · Derivative 115.803 $94.62 $10,957.28
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · derivative · entry 15

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Non-Qualified Retirement Plan

Disclosed balance after: 29,431.22

Underlying: Common Stock - Voting · 115.803 shares

Expires not disclosed

F2 · derivative.exercise_price: Dividend Reinvestment.

F2 · derivative.exercise_date: Dividend Reinvestment.

F2 · derivative.expiration_date: Dividend Reinvestment.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 22:49 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 322.9975 $28.38 $9,166.67
Disclosure

SEC source: 0001179110-22-000132 · edgar.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,018.2904

Underlying: Common Stock · 322.9975 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 318.9516 $28.74 $9,166.67
Disclosure

SEC source: 0001179110-21-010541 · edgar.xml · derivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,695.2929

Underlying: Common Stock · 318.9516 shares

Expires not disclosed

F2 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

F3 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

F2 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 7,307 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-010541 · edgar.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,267

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 27, 2021 Filed Dec 1, 2021 21:08 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionRestricted Stock Units · Derivative 28,042 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-21-011888 · form4.xml · derivative · entry 10

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock - Voting · 28,042 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units; No purchase price required.

F4 · price: The Restricted Stock Units granted on November 27, 2018.

F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning on November 27, 2019, November 27, 2020 and November 27, 2021.

F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning on November 27, 2019, November 27, 2020 and November 27, 2021.

Read SEC document
November 27, 2021 Filed Dec 1, 2021 21:08 UTC MCCORMICK & CO INC MKC · Entity 1416 Tax withholdingCommon Stock - Voting 13,545 $86.24 $1,168,120.80
Disclosure

SEC source: 0001062993-21-011888 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,829

F2 · balance_after: Due to administrative error, the Reporting Person's previous Form 4 filed on March 15, 2021 incorrectly reported the Reporting Person's direct holdings of Common Stock - Voting as 177,849 when it should have been reported as 174,332.

Read SEC document
November 27, 2021 Filed Dec 1, 2021 21:08 UTC MCCORMICK & CO INC MKC · Entity 1416 Exercise / conversionCommon Stock - Voting 28,042 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-21-011888 · form4.xml · nonDerivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units; No purchase price required.

Read SEC document
November 08, 2021 Filed Feb 1, 2022 19:14 UTC MCCORMICK & CO INC MKC · Entity 1416 GiftCommon Stock - Voting 12,690 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-001948 · form4.xml · nonDerivative · entry 2

Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,037

F1 · price: Shares gifted; no purchase price required.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:29 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 217.9644 $32.88 $7,166.67
Disclosure

SEC source: 0001179110-21-009768 · edgar.xml · derivative · entry 1

Kurzius Lawrence Erik · CIK 0001352090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,376.3413

Underlying: Common Stock · 217.9644 shares

Expires not disclosed

F1 · security: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021.

F1 · derivative.exercise_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Kurzius elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.